Cotización Verrica Parmaceuticals - VRCA

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

0.80

Postura de Compra

0.78

Postura de Venta

0.81

Volume Operado de la Acción

286,274

0.8495 Rango del Día 0.92

0.7043 Rango de 52 semanas 11.41

Capitalización de Mercado [m]

36.481M

Precio Anterior

0.89

Precio de Apertura

0.89

Hora

1376

0.8

(formt)

Última hora de negociación

Volumen financiero

US$ 255,528

Precio Promedio Ponderado

0.892601

Volumen promedio (3 m)

950,469

Acciones en circulación

45,600,795

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.61

Beneficio por acción (BPA)

-1.47

turnover

5.12M

Beneficio neto

-67M

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.verrica.com

Sede

Wilmington, Delaware, USA

Fundado

Verrica Parmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VRCA. The last closing price for Verrica Parmaceuticals was US$0.89. Over the last year, Verrica Parmaceuticals shares have traded in a share price range of US$ 0.7043 to US$ 11.41.

Verrica Parmaceuticals currently has 45,600,795 shares in issue. The market capitalisation of Verrica Parmaceuticals is US$40.58 million. Verrica Parmaceuticals has a price to earnings ratio (PE ratio) of -0.61.

Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements

Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.11	-12.0879120879	0.91	0.94	0.71	370383	0.86646491	CS
4	-0.79	-49.6855345912	1.59	1.7382	0.7043	769208	0.96308564	CS
12	-1.68	-67.7419354839	2.48	2.52	0.7043	950469	1.5284916	CS
26	-7.84	-90.7407407407	8.64	9.395	0.7043	676770	2.64786932	CS
52	-2.7	-77.1428571429	3.5	11.41	0.7043	664826	4.35252803	CS
156	-11.275	-93.3747412008	12.075	12.075	0.7043	366395	4.45744156	CS
260	-13.47	-94.3938332165	14.27	18.67	0.7043	260063	5.52956532	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
FBRXForte Biosciences Inc	US$ 13.60 (129.53%)	28.92M
QSIQuantum Si Inc	US$ 1.39 (119.59%)	279.33M
XCURExicure Inc	US$ 11.01 (89.18%)	22.91M
AGFYAgrify Corporation	US$ 37.4635 (68.00%)	921.45k
SLXNSilexion Therapeutics Corporation	US$ 0.3495 (54.51%)	198.66M
SKKSKK Holdings Limited	US$ 4.55 (-47.28%)	816.93k
QMMMQMMM Holdings Limited	US$ 0.713999 (-43.78%)	4.61M
XTKGX3 Holdings Company Ltd	US$ 0.0901 (-37.82%)	5.95M
PRFXPainReform Ltd	US$ 1.02 (-27.14%)	5.09M
GLEGlobal Engine Group Holding Ltd	US$ 3.81 (-26.59%)	230.23k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.191 (17.39%)	662.68M
DBGIDigital Brands Group Inc	US$ 0.1345 (15.35%)	326.45M
NVDANVIDIA Corporation	US$ 145.89 (-0.76%)	309.57M
QSIQuantum Si Inc	US$ 1.39 (119.59%)	283.09M
SLXNSilexion Therapeutics Corporation	US$ 0.3495 (54.51%)	200.06M